 insulin resistance hypertension metformin reduces blood pressure metabolic risk factors Insulin resistance hyperinsulinaemia important role development hypertension metabolic aberrations order possibility non-obese non-diabetic non-smoking middle-aged men untreated hypertension metformin mg b.i.d weeks pilot study within-patient comparison Metformin total LDL-cholesterol plasma insulin C-peptide levels Glucose disposal indicator insulin action means euglycaemic clamp technique Tissue plasminogen activator t-PA activity t-PA antigen whereas plasminogen activator inhibitor fibrinogen metformin treatment Body unchanged Withdrawal metformin return blood pressure metabolism initial levels conclusion metformin treatment insulin action blood pressure metabolic risk factor profile fibrinolytic activity hypertensive subjects results view insulin resistance role hypertension new field alleviation abnormalities cardiovascular disease